Medicare Enrolled
Dr. Gurinder Grewal, M.D.
Cardiovascular Disease · Tracy, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Grewal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grewal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Grewal
Dr. Gurinder Grewal is a cardiovascular disease specialist in Tracy, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Grewal performed 2,846 Medicare services across 1,553 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grewal received a total of $5,242 from 28 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grewal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 38% volume in CA
$5,242 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,846
Medicare services
Top 38% in CA for cardiovascular disease
1,553
Unique beneficiaries
$127
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~150 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,305 | $95 | $225 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
258 | $157 | $610 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
244 | $42 | $310 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
116 | $97 | $267 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
108 | $10 | $55 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 108 | $417 | $850 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
102 | $44 | $85 |
| Heart muscle strain imaging | 102 | $32 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
99 | $58 | $250 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
53 | $1,252 | $3,000 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
47 | $141 | $445 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
46 | $59 | $105 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
41 | $54 | $350 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
38 | $162 | $440 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $146 | $300 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
31 | $20 | $400 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
28 | $733 | $1,900 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
23 | $98 | $220 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
17 | $76 | $85 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
17 | $32 | $35 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $120 | $325 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $64 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.3% high complexity
19.6% medium
66.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,242
Total received (2018-2024)
Avg $749/year across 7 years
Top 39% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,025 (95.8%)
Other
Charitable contributions, space rental, and other categories
$128 (2.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$582
2023
$590
2022
$700
2021
$609
2020
$60
2019
$1,097
2018
$1,604
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$125
Janssen Pharmaceuticals, Inc
$123
E.R. Squibb & Sons, L.L.C.
$123
Kiniksa Pharmaceuticals International, plc
$96
Novartis Pharmaceuticals Corporation
$89
Abbott Laboratories
$26
Top 3 companies account for 63.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$745
E.R. Squibb & Sons, L.L.C.
$557
Novartis Pharmaceuticals Corporation
$524
Janssen Pharmaceuticals, Inc
$456
Boston Scientific Corporation
$409
Abbott Laboratories
$292
PFIZER INC.
$225
Medtronic Vascular, Inc.
$225
Merck Sharp & Dohme LLC
$200
Amgen Inc.
$192
SANOFI-AVENTIS U.S. LLC
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Baxter Healthcare
$128
Lilly USA, LLC
$125
Esperion Therapeutics, Inc.
$125
Teva Pharmaceuticals USA, Inc.
$125
BIOTRONIK INC.
$110
Kiniksa Pharmaceuticals International, plc
$96
Edwards Lifesciences Corporation
$81
Merck Sharp & Dohme Corporation
$74
GlaxoSmithKline, LLC.
$67
ShockWave Medical, Inc
$32
ASAHI INTECC USA, INC.
$31
ACIST MEDICAL SYSTEMS, INC.
$24
ATRICURE, INC.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Novo Nordisk Inc
$15
Shockwave Medical, Inc
$14
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
ALAIR · ASAHI PTCA Guide Wire · Arcalyst · BRILINTA · CAMZYOS · CARDIOMEMS · CINQAIR · CVI SYSTEMS · CardioMEMS HF System · Connectivity and Remote care · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EPIC VASCULAR · EV1000 Clinical Platform · FARXIGA · GENERAL THERAPIES · HawkOne · HeartMate 3 Left Ventricular Dev · INNOVA · JARDIANCE · JETSTREAM · LEQVIO · LOKELMA · MOUNJARO · Merlin Connectivity and Remote · Micra · NEXLIZET · PRADAXA · RXI CONSUMABLES · Repatha · Resolute · Reveal LINQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SPIRIVA RESPIMAT · TRELEGY ELLIPTA · TRULANCE · VERQUVO · VYNDAQEL · Vascular Lithotripsy · Victoza · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
49
Per 100K population
6.2
County median income
$88,531
Nearest hospital
SUTTER TRACY COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Grewal is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Grewal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Grewal performed 1,305 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grewal receive payments from pharmaceutical companies?
Yes. Dr. Grewal received a total of $5,242 from 28 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grewal's costs compare to other cardiologists in Tracy?
Dr. Grewal's average Medicare payment per service is $127. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grewal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Tracy
Browse cardiologists in Tracy ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology